Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients

The relevance of blood-based assays to monitor minimal residual disease (MRD) in non-metastatic prostate cancer (PCa) remains unclear. Proving that clinically relevant circulating tumor cells (CTCs) can be detected with available technologies could address this. This study aimed to improve CTC detec...

Full description

Bibliographic Details
Main Authors: Kuske, Andra, Gorges, Tobias M., Tennstedt, Pierre, Tiebel, Anne-Kathrin, Pompe, Raisa, Preißer, Felix, Prues, Sandra, Mazel, Martine, Markou, Athina, Lianidou, Evi, Peine, Sven, Alix-Panabières, Catherine, Riethdorf, Sabine, Beyer, Burkhard, Schlomm, Thorsten, Pantel, Klaus
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175156/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175156/

Similar Items